What does CUSIP 69012T206 represent in this 13F holders report?

CUSIP 69012T206 is the security identifier for OTLK - OUTLOOK THERAPEUTICS INC - COM NEW used to aggregate holder disclosures.

How many institutions held OTLK - OUTLOOK THERAPEUTICS INC - COM NEW in Q2 2020?

17 institutional investors reported OTLK - OUTLOOK THERAPEUTICS INC - COM NEW for Q2 2020. Use the holders table for investor-level position and value details.

OUTLOOK THERAPEUTICS INC - COM NEW (OTLK)

CUSIP: 69012T206

Q2 2020 13F Holders as of 30 Jun 2020

Security type / class: Equity / COM NEW
Total 13F shares: 1,677,230
Total 13F value: $2,166,000
Share change: -4,356,045
SEC-reported price per share: $1.30
Number of holders: 17
Value change: -$2,294,101
Number of buys: 15
Number of sells: 8

Security key

69012T206

Report period

Q2 2020

Institutions

Top holders

OTLK full security history Ownership snapshot Full 13F holder table Outlook Therapeutics, Inc. SEC filings Outlook Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of OTLK - OUTLOOK THERAPEUTICS INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

SABBY MANAGEMENT, LLC

Disclosed value leader

SABBY MANAGEMENT, LLC

Comparable rows

0/15

Latest evidence

31 Mar 2020

13F Highest disclosed value: $1,943,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

SABBY MANAGEMENT, LLC has the largest disclosed position value at $1.94M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SABBY MANAGEMENT, LLC's linked filing trail.

Disclosed position value Top 5

SABBY MANAGEMENT, LLC $1.94M

ARMISTICE CAPITAL, LLC $849K

VANGUARD GROUP INC $318K

LVW Advisors, LLC $263K

GEODE CAPITAL MANAGEMENT, LLC $40K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
SABBY MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$1,943,000 3,232,342 shares	—	31 Mar 2020
ARMISTICE CAPITAL, LLC	13F Company 13F	— denominator unverified	$849,000 1,412,382 shares	—	31 Mar 2020
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$318,000 529,130 shares	—	31 Mar 2020
LVW Advisors, LLC	13F Company 13F	— denominator unverified	$263,000 436,707 shares	—	31 Mar 2020
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$40,000 67,237 shares	—	31 Mar 2020
Bank of New York Mellon Corp	13F Company 13F	— denominator unverified	$31,000 50,858 shares	—	31 Mar 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,677,230

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Q2 2020 holders

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 value	Q2 2020 value	Value change	Value Chg %